The Biosimilar and Generics Tightrope:
Mastering the Regulatory Maze
Imagine Affordable access to life-saving biosimilars and generics, a medical landscape where cost doesn't limit access to crucial therapies. But wait, the path leading there is a dizzying tightrope stretched across a chasm of regulatory complexity. Fear not, intrepid explorer! Let's
